Rule: 64B16-27.500 Prev Up Next
| Rule Title: Negative Drug Formulary | |||
| Department: | DEPARTMENT OF HEALTH |
 Add to MyFLRules Favorites |
|
| Division: | Board of Pharmacy | ||
| Chapter: | PHARMACY PRACTICE | ||
Latest version of the final adopted rule presented in Florida Administrative Code (FAC):
|
Effective Date: | 3/18/2010 |
| History Notes: | Rulemaking Authority 465.005, 465.025(6) FS., Chapter 2001-146, Laws of Florida. Law Implemented 465.025(6) FS., Chapter 2001-146, Laws of Florida. History–New 12-14-76, Amended 3-17-77, 7-2-79, 4-9-81, 9-14-82, 9-26-84, Formerly 21S-5.01, Amended 3-30-89, 7-1-90, Formerly 21S-5.001, Amended 12-25-90, 10-1-92, Formerly 21S-27.500, Amended 2-21-94, Formerly 61F10-27.500, 59X-27.500, Amended 12-4-01, 3-18-10. | |
| References in this version: | No reference(s). |
| Notice / Adopted |
Description | ID | Publish Date |
|
|---|---|---|---|---|
|
Negative Drug Formulary | 8378877 |
Effective: 03/18/2010 |
|
|
Negative Drug Formulary | 8171394 |
1/22/2010 Vol. 36/03 |
|
|
|
The Board proposes the rule amendment in order to remove Levothyroxine Sodium from the negative drug formulary. | 8038504 |
12/18/2009 Vol. 35/50 |
|
|
|
The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list. | 7832864 |
10/30/2009 Vol. 35/43 |
|
|
|
Mylan Pharmaceuticals, Inc. vs. Department of Health, Board of Pharmacy and Board of Medicine and Abbott Laboratories ....; Case No.: 07-3704RX; Rule No.: 64B16-27.500; Invalid | 5308633 |
2/29/2008 Vol. 34/09 |
|
|
|
Mylan Pharmaceuticals, Inc. vs. Department of Health, Board of Pharmacy and Board of Medicine; Case No.: 07-3704RX; Rule No.: 64B16-27.500; Petition | 4609360 |
9/7/2007 Vol. 33/36 |
|
|
|
Negative Drug Formulary | 2470801 |
Effective: 12/04/2001 |
|